INVOBENITUG
UNII CFF2BLH47W

Substance Identification & Data

This profile provides standardized clinical and technical data for Invobenitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CFF2BLH47W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3034173-09-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CFF2BLH47W

CAS Registry Number

3034173-09-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INVOBENITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224748

National Cancer Institute reference terminology for clinical and research data.

INN ID

13742

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Invobenitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INVOBENITUG

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV2-5*01 (89.8%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT(10.7.8) (26-35.53-59.98-105)) (1-116) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (213) (117-214), HINGE 1-15 (215-229), CH2 (230-339), CH3 D12 (355), L14 (357) (340-444), CHS K2>DEL (445)) (117-445)), (219-219')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV2D-29*02 (91.0%) -IGKJ4*01 (100%), CDR-IMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (158'), V101 (196')) (113'-219')); DIMER (225-225'':228-228'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN DIPEPTIDYL PEPTIDASE III) (HUMAN-MUS MUSCULUS MONOCLONAL AK1967 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK1967 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS DPP3 (DIPEPTIDYL PEPTIDASE 3) LINEAR EPITOPE (I)NPETGEQIQ, HUMANIZED MONOCLONAL ANTIBODY (INVOBENITUG)

INVOBENITUG [INN]

PROCIZUMAB